Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

INmune Bio Inc. - Common stock (NQ:INMB)

2.735 +0.175 (+6.84%)
Streaming Delayed Price Updated: 10:21 AM EDT, Aug 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 19,457,402
Open 2.950
Bid (Size) 2.730 (11)
Ask (Size) 2.740 (61)
Prev. Close 2.560
Today's Range 2.690 - 2.955
52wk Range 1.890 - 11.64
Shares Outstanding 17,703,692
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What's going on in today's pre-market session
As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga

Performance

YTD
-44.5%
-44.5%
1 Month
+18.9%
+18.9%
3 Month
-63.8%
-63.8%
6 Month
-72.0%
-72.0%
1 Year
-64.2%
-64.2%

More News

Read More
INmune Bio’s CaRe PC Trial of INKmune™ in Metastatic Castration-Resistant Prostate Cancer Meets Endpoints and Is Closed to Enrollment
From INmune Bio, Inc.
Via GlobeNewswire
INmune Bio Inc. to Report Second Quarter 2025 Financial Results and Provide Corporate Update on Thursday, August 7th
From INmune Bio, Inc.
Via GlobeNewswire
INmune Bio to Publish Video Detailing MINDFuL Trial Findings of XPro™ Presented at the Alzheimer’s Association International Conference
From INmune Bio, Inc.
Via GlobeNewswire
Why Celcuity Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
INmune Bio Rebounds Sharply During After Hours Trading: What's Driving the Surge?
Via Benzinga
INmune Bio to Present Phase 2 MINDFuL Trial Findings of XPro™ at the Alzheimer’s Association International Conference
From INmune Bio, Inc.
Via GlobeNewswire
'Pharma Bro' Martin Shkreli Says 'Good Chance' Inmune Bio Stock Will Slip 90% On Monday
Via Benzinga
Which stocks have an unusual volume on Thursday?
Via Chartmill
This Textron Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Via Benzinga
INmune Bio, Inc. Announces Closing of Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
From INmune Bio, Inc.
Via GlobeNewswire
Let's take a look at the stocks that are in motion in today's session.
Via Chartmill
Crude Oil Moves Lower; Joby Aviation Shares Surge
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Which stocks are moving on Monday?
Via Chartmill
Alzheimer's Setback Hits INmune Bio Stock, But FDA Hopes Remain
Via Benzinga
Dow Gains Over 100 Points; Chicago PMI Weakens In June
Via Benzinga
Topics Stocks
Gapping stocks in Monday's session
Via Chartmill
INmune Bio Stock Slumps After Alzheimer’s Drug Falls Short In Mid-Stage Trial
Via Stocktwits
Get insights into the top gainers and losers of Monday's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
INmune Bio Reports Key Findings from Phase 2 MINDFuL Trial of XPro™ in Early Alzheimer’s Disease
From INmune Bio, Inc.
Via GlobeNewswire
Why Venus Concept Shares Are Trading Higher By Over 32%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Via Chartmill

Frequently Asked Questions

Is INmune Bio Inc. - Common stock publicly traded?
Yes, INmune Bio Inc. - Common stock is publicly traded.
What exchange does INmune Bio Inc. - Common stock trade on?
INmune Bio Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for INmune Bio Inc. - Common stock?
The ticker symbol for INmune Bio Inc. - Common stock is INMB on the Nasdaq Stock Market
What is the current price of INmune Bio Inc. - Common stock?
The current price of INmune Bio Inc. - Common stock is 2.735
When was INmune Bio Inc. - Common stock last traded?
The last trade of INmune Bio Inc. - Common stock was at 08/04/25 10:21 AM ET
What is the market capitalization of INmune Bio Inc. - Common stock?
The market capitalization of INmune Bio Inc. - Common stock is 48.42M
How many shares of INmune Bio Inc. - Common stock are outstanding?
INmune Bio Inc. - Common stock has 48M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.